Furthermore, it has been confirmed that efficient uptake of glutamine and leucine through SLC1A5, SLC7A5, and SLC3A2 can enhance metabolic capacity and effector functions of NK and T cells targeting tumors for improved tumor recognition and infiltration [79, 80]. This evidence concerns the gene SLC3A2 and neoplasm.